Clinical trial
Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients…
NCT00152594 · University of Cologne, Other · Terminated
Key facts
| NCT number | NCT00152594 |
|---|---|
| Title | Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia |
| Official title | Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia |
| Lead sponsor | University of Cologne, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute |
| Intervention type | Drug |
| Interventions | voriconazole |
| Enrollment | 150 |
| Start date | Oct 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Nov 14, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: